Clinical Certificate



Attendance at three Certificate Modules.

A Certificate, signed by the BAP President, will be awarded, confirming participation in the modules.


  1. Part 1 Certificate plus
  2. Attendance at either a BAP Summer Meeting or a one-day Meeting whilst undertaking the Certificate
  3. Dissertation

3.1 Options for Dissertation

The Dissertation should be a minimum of 5,000 words (maximum 10,000 words) with a minimum of 15 references cited in the text. The references should mostly be original work published in reputable journals. The following forms of written dissertation will be considered:

  • Log Book Option: This will consist of a write-up of the drug treatment of three cases treated personally by the candidate. There should be one case of psychosis, one case of neurosis and one other case described in the dissertation. The discussion should focus on psychopharmacological issues arising out of the case.
  • Research Option: This should be an original piece of research not yet submitted for publication and the research should directly concern psychopharmacology and involve drugs. There should be a clear hypothesis.
    Surveys (Stages I & II of audit cycle) are acceptable forms of research.
    Literature Reviews using appropriate systematic searches and meta-analysis are also acceptable.

3.2 Format

  • 5,000–10,000 words, typed, double-spaced, bound with stiff cover (e.g. spiral bound), numbered.
  • Front page should include candidate's name and location, supervisor's name, option chosen.
  • Abstract (400 words max) on a separate page.
  • Frequent headings and sub-headings, including: Introduction, Background, Patient logs research, General Discussion, Conclusions.

3.3 Supervision

Candidates will be allocated a Supervisor after one or two modules, and should have two sessions with their supervisor during the course of their dissertation. The contact could be face-to-face, but may also be by telephone/fax/email.

3.4 Part 2 Certificate Award Criteria

For all dissertations:

  • evidence of original thought
  • realistic references from accessible journals
  • key references cited
  • critical interaction with literature
  • state of the art knowledge of clinical psychopharmacology
  • full understanding of mechanisms of drug action
  • full understanding and discussion of pharmacokinetic drug properties
  • post membership standard

In addition: Logbook option

  • one case of psychosis; one of neurosis and one other
  • clear description of cases with appropriate diagnosis
  • clear rationale for, or critical discussion of current and past therapeutic decisions
  • evidence of personal involvement in patient contact

In addition: Research option

  • clear hypothesis, i.e. a clear theoretical issue tested with a falsifiable prediction
  • discussion of power issues and sample sizes
  • appropriate statistics and knowledgeable discussion of choice of statistical methodology
  • validated clinical measures
  • personal involvement with data gathering
  • surveys in the format of audit Stages I & II
  • literature review – clear account of search method and its effectiveness, and use of statistics of meta-analysis (where appropriate)

The Part 2 Certificate course may be started at any point during the year. After attending their second module, candidates must contact their supervisor (allocated by the BAP Office) and before attending the third module should produce a written plan of their submission, together with a projected deadline for the final submission. The final submission must be no later than two years after attendance at the second module.

Complete Registration of Interest form